MusclePharm
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. MusclePharm's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 22% to $50,042,000. Profit margin reached -26%. Total operating expenses were $14,284,000.

Profit Margin

MusclePharm Corporation (OTC:MSLP): Profit margin
2012 67.05M -18.95M -28.26%
2013 110.87M -17.71M -15.98%
2014 177.38M -13.83M -7.8%
2015 166.85M -51.85M -31.08%
2016 132.49M -3.47M -2.62%
2017 102.15M -10.97M -10.74%
2018 88.11M -10.75M -12.21%
2019 79.66M -18.92M -23.76%
2020 64.44M 3.18M 4.94%
2021 50.04M -12.88M -25.74%

MSLP Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
50.04M64.44M79.66M88.11M102.15M132.49M166.85M177.38M110.87M67.05M
Cost of revenue
44.67M44.83M70.97M69.71M71.71M88.02M109.92M121.37M77.68M52.72M
Gross profit
5.37M19.60M8.68M18.39M30.44M44.47M56.93M56.01M33.19M14.32M
Operating exp.
Research and development
00893K751K642K1.86M4.25M3.99M1.11M0
Selling and marketing
4.39M507K2.48M2.93M9.35M10.65M26.98M28.05M15.53M8.43M
Total operating expenses
14.28M16.84M23.79M26.22M37.45M52.23M88.58M75.38M47.48M23.06M
Operating income
-7.39M4.86M-15.08M-6.85M-7.57M-1.51M-50.97M-13.59M-16.81M-8.73M
Other income (expenses), net
-5.47M564K-3.75M-3.8M-3.64M-1.64M-779K-201K-783.31K-10.21M
Income before tax
-12.87M3.16M-18.84M-10.65M-10.83M-3.15M-51.75M-13.79M-17.60M-18.95M
Income tax expense
8K-19K86K100K142K318K105K33K115.48K0
Net income
-12.88M3.18M-18.92M-10.75M-10.97M-3.47M-51.85M-13.83M-17.71M-18.95M
Earnings per share
Basic EPS
-0.310.07-0.92-0.72-0.79-0.26-3.81-1.25-2.46-13
Diluted EPS
-0.310.07-0.92-0.72-0.79-0.26-3.81-1.25-2.46-13
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source